Seasonal Influenza Vaccines

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)

Source: Find a Tender
Type: Contract (Supply)
Duration: 1 year (est.)
Value: £15M

Sector: HEALTH
Published: 21 Mar 2024
Delivery: To 21 Mar 2025 (est.)
Deadline: n/a

Concepts

Location

Goods should be delivered to the Authority's nominated storage and distribution provider. Details will be shared with awarded Contractor(s) in due course.

Geochart for 2 buyers and 3 suppliers

2 buyers

NHS National Services Scotland NSS Edinburgh

1 supplier

Seqirus Liverpool

Description

Supply of influenza vaccines for use in the NHS Scotland 2024/25 Seasonal Flu Programme.

Lot Division

Influenza Vaccine for adults aged 65 years and above, as recommended by JCVI for 2024/25

Supply of influenza vaccines as recommended by JCVI for adults aged 65 years and above to NHS Scotland for use in the 2024/25 NHS Scotland Seasonal Flu Programme. This Lot is awarded as a Commitment Contract to a single supplier.

Influenza Vaccine for Persons aged 18 to 64 years, as recommended by JCVI for 2024/25

Supply of influenza vaccines as recommended by JCVI for adults aged 18 to 64 years to NHS Scotland for use in the 2024/25 NHS Scotland Seasonal Flu Programme. This Lot is awarded as a Commitment Contract to a single supplier.

Cell-culture Influenza Vaccine for children aged 6 months to 17 years, as recommended by JCVI for 2024/25

Supply of cell-culture influenza vaccines as recommended by JCVI for children aged 6 months to 17 years to NHS Scotland for use in the 2024/25 NHS Scotland Seasonal Flu Programme. This Lot is awarded as a Commitment Contract to a single supplier.

Award Detail

1	Seqirus (Liverpool) Influenza Vaccine for adults aged 65 years and above, as recommended by JCVI for 2024/25 Num offers: 1 Value: £9,000,000.0-£10,000,000
2	Seqirus (Liverpool) Influenza Vaccine for Persons aged 18 to 64 years, as recommended by JCVI for 2024/25 Num offers: 1 Value: £5,000,000.0-£6,000,000
3	Seqirus (Liverpool) Cell-culture Influenza Vaccine for children aged 6 months to 17 years, as recommended by JCVI for 2024/25 Num offers: 1 Value: £200,000.0-£300,000

Award Criteria

Delivery Schedule	10.0
PRICE	90.0

CPV Codes

33651660 - Influenza vaccines

Indicators

Award on basis of price.

Legal Justification

Vaccine manufacturers have advised that Contracts for supply of flu vaccines for the 2024/25 flu programme must be awarded no later than February to secure the required volumes and manufacturing capacity with their manufacturing sites.